Data analytics company Palantir Technologies has won a $44.4 million contract from the U.S. Food and Drug Administration.
The three-year contract covers data and analytics services to the FDA’s Center for Drug Evaluation and Research (CDER) to speed its review of potential new medicines. It is one of dozens that Palantir has with the U.S. government.
The contract also provides services to the FDA’s Oncology Center of Excellence, which helps with the development and review of cancer products.
Palantir also provides data analytics for the U.S. Army, and the National Institutes of Health, among others. It is working with the federal government on a system for tracking the distribution of expected COVID-19 vaccines as they are distributed to healthcare providers around the country.
Denver-based Palantir went public in September through a direct listing that valued it at more than $20 billion.
The company earned about half its revenue, $163 million, from its government contracting business in the most recent quarter. Palantir was co-founded by billionaire Peter Thiel in 2003.